Drug
Mivacurium
Mivacurium is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (50.0%)
N/A1 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completed
Mivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients
NCT05558137
completed
Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals
NCT02914119
completednot_applicable
Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy
NCT01966484
completedphase_1
Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium
NCT01906528
Clinical Trials (4)
Showing 4 of 4 trials
NCT05558137
Mivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients
NCT02914119
Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals
NCT01966484Not Applicable
Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy
NCT01906528Phase 1
Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4